Global vaccine experts and officials from all 26 African ‘meningitis belt’ countries have convened in Addis Ababa, Ethiopia, to celebrate one of Africa’s biggest public health achievements — the introduction of a vaccine designed, developed, and produced for use in Africa, that in five years of use has nearly eliminated serogroup A meningococcal disease from meningitis belt countries and is now being integrated into routine national immunization programs.